• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MLA
Click for more information
0.00% 8.5¢

MEDICAL AUSTRALIA LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
MLA Suspension from Official Quotation (COB 20/11/2017)PRICE SENSITIVE20/11/17
MLA COURT APPROVES SCHEME OF ARRANGEMENTPRICE SENSITIVE17/11/17
MLA MLA SHAREHOLDERS APPROVE SCHEMEPRICE SENSITIVE15/11/17
MLA Appendix 4C - quarterlyPRICE SENSITIVE19/10/17
MLA DISPATCH OF SCHEME BOOKLET TO SHAREHOLDERSPRICE SENSITIVE13/10/17
MLA Court approves Scheme Booklet and Convening of MeetingPRICE SENSITIVE04/10/17
MLA APPENDIX 4E AND PRELIMINARY FINAL REPORTPRICE SENSITIVE30/08/17
MLA MLA & ICU MEDICAL INC SIGNS SCHEME IMPLEMENTATION AGREEMENTPRICE SENSITIVE10/08/17
MLA MLA records revenue of $3.29 million for Q4 FY2017PRICE SENSITIVE31/07/17
MLA Appendix 4C March 2017 QuarterPRICE SENSITIVE26/04/17
MLA Half Yearly Report and AccountsPRICE SENSITIVE28/02/17
MLA Ardo Breast Pump AgreementPRICE SENSITIVE22/02/17
MLA Quarterly ReportPRICE SENSITIVE31/01/17
MLA Appendix 4C - quarterlyPRICE SENSITIVE31/01/17
MLA Quarterly Report-MLA.AX PRICE SENSITIVE31/10/16
MLA Appendix 4C - quarterly-MLA.AX PRICE SENSITIVE31/10/16
MLA Progress Report-MLA.AX PRICE SENSITIVE05/09/16
MLA Preliminary Final Report-MLA.AX PRICE SENSITIVE31/08/16
MLA Appendix 4C - quarterly-MLA.AX PRICE SENSITIVE29/07/16
MLA Quarterly Cashflow Report-MLA.AX PRICE SENSITIVE29/07/16
MLA Distribution Agreement with Ardo-MLA.AX PRICE SENSITIVE17/05/16
MLA Appendix 4C and Commentary-MLA.AX PRICE SENSITIVE13/04/16
MLA Medical Australia Limited Interim Financial ReportPRICE SENSITIVE29/02/16
MLA Response to ASX Appendix 4C QueryPRICE SENSITIVE10/02/16
MLA Exclusive Distribution Rights for DuelCap System SecuredPRICE SENSITIVE08/02/16
MLA Appendix 4C - 31 December 2015PRICE SENSITIVE29/01/16
MLA MLA Finalises Sale of MediVetPRICE SENSITIVE22/12/15
MLA Medivet Biologics US Animal Health BusinessPRICE SENSITIVE13/11/15
MLA Appendix 4C - 30 September 2015PRICE SENSITIVE30/10/15
MLA Appendix 4E - 30 June 2015PRICE SENSITIVE31/08/15
MLA Response to Appendix 4C QueryPRICE SENSITIVE07/08/15
MLA Appendix 4C - 30 June 2015PRICE SENSITIVE31/07/15
MLA Focus on Human Healthcare & Dilution of Animal BusinessPRICE SENSITIVE23/06/15
MLA Appendix 4C - 31 March 2015PRICE SENSITIVE30/04/15
MLA Quarterly Report - 31 March 2015PRICE SENSITIVE30/04/15
MLA Quarterly Report for Period Ended 31 December 2014PRICE SENSITIVE27/02/15
MLA Quarterly Report & Appendix 4C - 31 December 2014PRICE SENSITIVE30/01/15
MLA MLA Subsidiary to help Develop Canine Cancer TreatmentPRICE SENSITIVE19/01/15
MLA Darryl Ellis appointed as CEO of Medical Australia LimitedPRICE SENSITIVE02/12/14
MLA Appendix 4C - 30.9.14PRICE SENSITIVE28/10/14
MLA Quarterly Report - September 2014PRICE SENSITIVE28/10/14
MLA Non-Renounceable Rights Issue Offer DocumentPRICE SENSITIVE14/10/14
MLA Notice of Intention to Offer a Rights IssuePRICE SENSITIVE13/10/14
MLA Appendix 4E - 30 June 2014PRICE SENSITIVE29/08/14
MLA Appendix 4CPRICE SENSITIVE30/07/14
MLA MediVet Successful in out of Court SettlementPRICE SENSITIVE07/07/14
MLA MLA licensed for distribution of nanofiber animal technologyPRICE SENSITIVE03/07/14
MLAQuarterly Report & Appendix 4C - March 2014PRICE SENSITIVE30/04/14
MLAAppendix 4D & Half-Yearly ReportPRICE SENSITIVE28/02/14
MLABoard and Management ChangesPRICE SENSITIVE13/02/14
MLAQuarterly Report December 2013PRICE SENSITIVE31/01/14
MLAAppendix 4CPRICE SENSITIVE31/01/14
MLAResponse to ASX Price Query LetterPRICE SENSITIVE16/01/14
MLAMLA Raises $4 Million To Fast Track GrowthPRICE SENSITIVE10/12/13
MLAAppendix 4CPRICE SENSITIVE25/10/13
MLAMLA signs agreement to acquire MediVetPRICE SENSITIVE24/09/13
MLAAppendix 4EPRICE SENSITIVE30/08/13
MLAAppendix 4C - Quarter June 2013PRICE SENSITIVE31/07/13
MLAMLA Announces Acquisition of MedivetPRICE SENSITIVE06/06/13
MLAAppendix 4CPRICE SENSITIVE30/04/13
MLAMLA Expands OEM AgreementsPRICE SENSITIVE22/04/13
MLAMLA strengthens UK presence with NHS Trust Supply AgreementPRICE SENSITIVE12/03/13
MLAHalf Year ReportPRICE SENSITIVE28/02/13
MLAResponse to ASX Query - Appendix 4CPRICE SENSITIVE12/02/13
MLAAppendix 4CPRICE SENSITIVE30/01/13
ALT +FirstFlow Burette market updatePRICE SENSITIVE15/11/12
MLAAppendix 4CPRICE SENSITIVE26/10/12
MLAAppendix 4EPRICE SENSITIVE28/08/12
MLAAppendix 4CPRICE SENSITIVE30/07/12
MLAMLA successfully completes first animal stem cell treatmentPRICE SENSITIVE30/04/12
MLAAppendix 4CPRICE SENSITIVE30/04/12
MLAMLA first in Europe to cryogenically freeze stem cellsPRICE SENSITIVE03/04/12
MLAAppendix 4DPRICE SENSITIVE28/02/12
MLAAppendix 4CPRICE SENSITIVE25/01/12
MLAMLA secures over $1.5 million in new supply agreementsPRICE SENSITIVE22/11/11
MLAAppendix 4CPRICE SENSITIVE27/10/11
MLAMLA secures new distribution agreementPRICE SENSITIVE23/08/11
MLAAppendix 4EPRICE SENSITIVE22/08/11
MLAMLA well funded in cash following Option ConversionPRICE SENSITIVE25/07/11
MLAAppendix 4C - quarterlyPRICE SENSITIVE22/07/11
ALT +Supply Agreement for AnalyticaPRICE SENSITIVE06/07/11
MLASecures Master Distributorship for MediVet in UKPRICE SENSITIVE05/07/11
ALT +Supply Agreement with NSW Ambulance ServicePRICE SENSITIVE12/05/11
MLANew supply contract with UNICEFPRICE SENSITIVE11/05/11
MLAAppendix 4CPRICE SENSITIVE15/04/11
MLANew supply agreement with HealthscopePRICE SENSITIVE04/04/11
MLAMLA secures new distribution agreement with HaemoneticsPRICE SENSITIVE28/03/11
MLAAppendix 4DPRICE SENSITIVE22/02/11
MLAAppendix 4CPRICE SENSITIVE25/01/11
MLAMLA delivers 18% increase in half year revenue to $4.6 millPRICE SENSITIVE25/01/11
MLALandmark OEM agreement with leading global medical device coPRICE SENSITIVE11/01/11
MLAUpdate on Care Essentials and Placement of ShortfallPRICE SENSITIVE25/11/10
MLAThree year OEM supply agreement with Terumo Medical CorpPRICE SENSITIVE23/11/10
MLAAppendix 4CPRICE SENSITIVE26/10/10
MLAUpdate on Care Essentials TransactionPRICE SENSITIVE01/09/10
MLAAppendix 4EPRICE SENSITIVE31/08/10
MLAAppendix 4CPRICE SENSITIVE29/07/10
MLAMLA secures multi-million dollar global agreement - MedivetPRICE SENSITIVE12/07/10
MLARights Issue ProspectusPRICE SENSITIVE03/06/10
MLAAppendix 4CPRICE SENSITIVE29/04/10
MLA Suspension from Official Quotation (COB 20/11/2017)
20/11/17PRICE SENSITIVE
MLA COURT APPROVES SCHEME OF ARRANGEMENT
17/11/17PRICE SENSITIVE
MLA MLA SHAREHOLDERS APPROVE SCHEME
15/11/17PRICE SENSITIVE
MLA Appendix 4C - quarterly
19/10/17PRICE SENSITIVE
MLA DISPATCH OF SCHEME BOOKLET TO SHAREHOLDERS
13/10/17PRICE SENSITIVE
MLA Court approves Scheme Booklet and Convening of Meeting
04/10/17PRICE SENSITIVE
MLA APPENDIX 4E AND PRELIMINARY FINAL REPORT
30/08/17PRICE SENSITIVE
MLA MLA & ICU MEDICAL INC SIGNS SCHEME IMPLEMENTATION AGREEMENT
10/08/17PRICE SENSITIVE
MLA MLA records revenue of $3.29 million for Q4 FY2017
31/07/17PRICE SENSITIVE
MLA Appendix 4C March 2017 Quarter
26/04/17PRICE SENSITIVE
MLA Half Yearly Report and Accounts
28/02/17PRICE SENSITIVE
MLA Ardo Breast Pump Agreement
22/02/17PRICE SENSITIVE
MLA Quarterly Report
31/01/17PRICE SENSITIVE
MLA Appendix 4C - quarterly
31/01/17PRICE SENSITIVE
MLA Quarterly Report-MLA.AX
31/10/16PRICE SENSITIVE
MLA Appendix 4C - quarterly-MLA.AX
31/10/16PRICE SENSITIVE
MLA Progress Report-MLA.AX
05/09/16PRICE SENSITIVE
MLA Preliminary Final Report-MLA.AX
31/08/16PRICE SENSITIVE
MLA Appendix 4C - quarterly-MLA.AX
29/07/16PRICE SENSITIVE
MLA Quarterly Cashflow Report-MLA.AX
29/07/16PRICE SENSITIVE
MLA Distribution Agreement with Ardo-MLA.AX
17/05/16PRICE SENSITIVE
MLA Appendix 4C and Commentary-MLA.AX
13/04/16PRICE SENSITIVE
MLA Medical Australia Limited Interim Financial Report
29/02/16PRICE SENSITIVE
MLA Response to ASX Appendix 4C Query
10/02/16PRICE SENSITIVE
MLA Exclusive Distribution Rights for DuelCap System Secured
08/02/16PRICE SENSITIVE
MLA Appendix 4C - 31 December 2015
29/01/16PRICE SENSITIVE
MLA MLA Finalises Sale of MediVet
22/12/15PRICE SENSITIVE
MLA Medivet Biologics US Animal Health Business
13/11/15PRICE SENSITIVE
MLA Appendix 4C - 30 September 2015
30/10/15PRICE SENSITIVE
MLA Appendix 4E - 30 June 2015
31/08/15PRICE SENSITIVE
MLA Response to Appendix 4C Query
07/08/15PRICE SENSITIVE
MLA Appendix 4C - 30 June 2015
31/07/15PRICE SENSITIVE
MLA Focus on Human Healthcare & Dilution of Animal Business
23/06/15PRICE SENSITIVE
MLA Appendix 4C - 31 March 2015
30/04/15PRICE SENSITIVE
MLA Quarterly Report - 31 March 2015
30/04/15PRICE SENSITIVE
MLA Quarterly Report for Period Ended 31 December 2014
27/02/15PRICE SENSITIVE
MLA Quarterly Report & Appendix 4C - 31 December 2014
30/01/15PRICE SENSITIVE
MLA MLA Subsidiary to help Develop Canine Cancer Treatment
19/01/15PRICE SENSITIVE
MLA Darryl Ellis appointed as CEO of Medical Australia Limited
02/12/14PRICE SENSITIVE
MLA Appendix 4C - 30.9.14
28/10/14PRICE SENSITIVE
MLA Quarterly Report - September 2014
28/10/14PRICE SENSITIVE
MLA Non-Renounceable Rights Issue Offer Document
14/10/14PRICE SENSITIVE
MLA Notice of Intention to Offer a Rights Issue
13/10/14PRICE SENSITIVE
MLA Appendix 4E - 30 June 2014
29/08/14PRICE SENSITIVE
MLA Appendix 4C
30/07/14PRICE SENSITIVE
MLA MediVet Successful in out of Court Settlement
07/07/14PRICE SENSITIVE
MLA MLA licensed for distribution of nanofiber animal technology
03/07/14PRICE SENSITIVE
MLAQuarterly Report & Appendix 4C - March 2014
30/04/14PRICE SENSITIVE
MLAAppendix 4D & Half-Yearly Report
28/02/14PRICE SENSITIVE
MLABoard and Management Changes
13/02/14PRICE SENSITIVE
MLAQuarterly Report December 2013
31/01/14PRICE SENSITIVE
MLAAppendix 4C
31/01/14PRICE SENSITIVE
MLAResponse to ASX Price Query Letter
16/01/14PRICE SENSITIVE
MLAMLA Raises $4 Million To Fast Track Growth
10/12/13PRICE SENSITIVE
MLAAppendix 4C
25/10/13PRICE SENSITIVE
MLAMLA signs agreement to acquire MediVet
24/09/13PRICE SENSITIVE
MLAAppendix 4E
30/08/13PRICE SENSITIVE
MLAAppendix 4C - Quarter June 2013
31/07/13PRICE SENSITIVE
MLAMLA Announces Acquisition of Medivet
06/06/13PRICE SENSITIVE
MLAAppendix 4C
30/04/13PRICE SENSITIVE
MLAMLA Expands OEM Agreements
22/04/13PRICE SENSITIVE
MLAMLA strengthens UK presence with NHS Trust Supply Agreement
12/03/13PRICE SENSITIVE
MLAHalf Year Report
28/02/13PRICE SENSITIVE
MLAResponse to ASX Query - Appendix 4C
12/02/13PRICE SENSITIVE
MLAAppendix 4C
30/01/13PRICE SENSITIVE
ALT +FirstFlow Burette market update
15/11/12PRICE SENSITIVE
MLAAppendix 4C
26/10/12PRICE SENSITIVE
MLAAppendix 4E
28/08/12PRICE SENSITIVE
MLAAppendix 4C
30/07/12PRICE SENSITIVE
MLAMLA successfully completes first animal stem cell treatment
30/04/12PRICE SENSITIVE
MLAAppendix 4C
30/04/12PRICE SENSITIVE
MLAMLA first in Europe to cryogenically freeze stem cells
03/04/12PRICE SENSITIVE
MLAAppendix 4D
28/02/12PRICE SENSITIVE
MLAAppendix 4C
25/01/12PRICE SENSITIVE
MLAMLA secures over $1.5 million in new supply agreements
22/11/11PRICE SENSITIVE
MLAAppendix 4C
27/10/11PRICE SENSITIVE
MLAMLA secures new distribution agreement
23/08/11PRICE SENSITIVE
MLAAppendix 4E
22/08/11PRICE SENSITIVE
MLAMLA well funded in cash following Option Conversion
25/07/11PRICE SENSITIVE
MLAAppendix 4C - quarterly
22/07/11PRICE SENSITIVE
ALT +Supply Agreement for Analytica
06/07/11PRICE SENSITIVE
MLASecures Master Distributorship for MediVet in UK
05/07/11PRICE SENSITIVE
ALT +Supply Agreement with NSW Ambulance Service
12/05/11PRICE SENSITIVE
MLANew supply contract with UNICEF
11/05/11PRICE SENSITIVE
MLAAppendix 4C
15/04/11PRICE SENSITIVE
MLANew supply agreement with Healthscope
04/04/11PRICE SENSITIVE
MLAMLA secures new distribution agreement with Haemonetics
28/03/11PRICE SENSITIVE
MLAAppendix 4D
22/02/11PRICE SENSITIVE
MLAAppendix 4C
25/01/11PRICE SENSITIVE
MLAMLA delivers 18% increase in half year revenue to $4.6 mill
25/01/11PRICE SENSITIVE
MLALandmark OEM agreement with leading global medical device co
11/01/11PRICE SENSITIVE
MLAUpdate on Care Essentials and Placement of Shortfall
25/11/10PRICE SENSITIVE
MLAThree year OEM supply agreement with Terumo Medical Corp
23/11/10PRICE SENSITIVE
MLAAppendix 4C
26/10/10PRICE SENSITIVE
MLAUpdate on Care Essentials Transaction
01/09/10PRICE SENSITIVE
MLAAppendix 4E
31/08/10PRICE SENSITIVE
MLAAppendix 4C
29/07/10PRICE SENSITIVE
MLAMLA secures multi-million dollar global agreement - Medivet
12/07/10PRICE SENSITIVE
MLARights Issue Prospectus
03/06/10PRICE SENSITIVE
MLAAppendix 4C
29/04/10PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
HotCopper Highlights: Your most watched stocks for Week 48, 2024 Good afternoon, a happy end of the week, and welcome to HotCopper Highlights – I’m Jonathon Davidson. Let’s get into it.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia New Zealand’s Reserve Bank has taken a bold step, slashing rates by 50 basis points to 4.25% @ its third cut in just four months. Meanwhile, the Reserve Bank of Australia holds firm at 4.35%, its highest rate in over a decade.This stark policy divergence highlights contrasting glo...
Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher Vitrafy Life Sciences Limited (ASX:VFY) has defied this month’s odds to become the only newly-listed Australian company to survive a surprisingly rough November (for newcomers, at least) without sagging below its IPO price.The cryopreservation biotech did give some back on Friday,...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.